Infectious cell culture supernatant containing SARS-CoV-2 (strain hCoV-19/Slovenia/LP3/58/23; lineage Omicron, FL.15). This strain is preserved in viral storage medium -80°C.
Infectious cell culture supernatant containing SARS-CoV-2, VUM GRA (XBB.1.9.1+XBB.1.9.1.*) first detected in Indonesia/Israel/Singapore, strain hCoV-19/Italy/LAZ-INMI-4945/2023, A27S, D405N, D614G, D796Y, E484A, F486P, F
Infectious cell culture supernatant containing SARS-CoV-2, VOI GRA (XBB.1.16+XBB.1.16.*) first detected in India, strain hCoV-19/Italy/LAZ-INMI-5327/2023, A27S, D405N, D614G, D796Y, E180V, E484A, F486P, F490S, G142D, G25
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-001. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-002. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P8-GII.8/NV-23-003. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-004. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GII.P16-GII.4/NV-23-005. Material 10-20% fecal material in virus culture medium.
Access to RIVM infrastructure to use anonymized human fecal material containing fully sequenced norovirus strain Hu/NL/2023/GI.P5-GI.5/NV-23-006. Material 10-20% fecal material in virus culture medium.